|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Myelopathy | |||||
| AIDS-Myelopathy | |||||
| AIDS Vacuolar Myelopathy | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Acquired Immunodeficiency Syndrome | |||||
| Spinal Cord Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Central Nervous System Diseases | |||||
| HIV Infections | |||||
| Immune System Diseases | |||||
| Immunologic Deficiency Syndromes | |||||
| Lentivirus Infections | |||||
| Nervous System Diseases | |||||
| Retroviridae Infections | |||||
| RNA Virus Infections | |||||
| Sexually Transmitted Diseases | |||||
| Sexually Transmitted Diseases, Viral | |||||
| Slow Virus Diseases | |||||
| Virus Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| methionine | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute of Neurological Disorders and Stroke (NINDS) | |||||